News Releases

Advancements in Technology and Patient Access Deliver Better Clinical Trial Access, Quality, and Experiences BURLINGTON, N.C. --(BUSINESS WIRE)--Oct. 20, 2020-- LabCorp (NYSE: LH), a leading global life sciences company that is focused on advancing health and guiding patient care decisions, today

BURLINGTON, N.C. --(BUSINESS WIRE)--Oct. 19, 2020-- LabCorp (NYSE: LH), a leading global life sciences company that is focused on advancing health and guiding patient care decisions, and Swedish, the largest nonprofit healthcare system in the Puget Sound region, today announced an agreement to

Quantitative Test is Used to Assess Immune Response and to Support Other Scientific Research BURLINGTON, N.C. --(BUSINESS WIRE)--Oct. 19, 2020-- LabCorp (NYSE: LH), a leading global life sciences company that is focused on advancing health and guiding patient care, today announced a test that

Android Phone Users Now Have Easy Access to Their Test Results as Popularity of Telehealth Rises BURLINGTON, N.C. --(BUSINESS WIRE)--Oct. 13, 2020-- LabCorp (NYSE: LH), a leading global life sciences company that is focused on advancing health and guiding patient care decisions, and The Commons

New Software Tool Designed to Help Oncologists Improve Patient Outcomes and Achieve Cost-Saving Goals Available Exclusively through LabCorp and Powered by HealthEC® BURLINGTON, N.C. & EDISON, N.J. --(BUSINESS WIRE)--Oct. 9, 2020-- LabCorp (NYSE: LH), a leading global life sciences company that is

Eases the Ability to Safely Travel , Enter Workplaces, and Attend Public Events NEW YORK & BURLINGTON, N.C. --(BUSINESS WIRE)--Oct. 5, 2020-- CLEAR, the secure identity company, and LabCorp (NYSE: LH), a leading global life sciences company that is focused on advancing health and guiding patient

New Heat Extraction Scientific Testing Method and Technology Improves COVID-19 Molecular Test Efficiency and Throughput BURLINGTON, N.C. --(BUSINESS WIRE)--Oct. 2, 2020-- LabCorp (NYSE: LH), a leading global life sciences company that is focused on advancing health and guiding patient care

Consortium members will work together to increase opportunities to accelerate research through enhanced collaboration and information sharing, with the ultimate goal of improving aspects of COVID-19 testing across the globe Widespread accurate testing for SARS-CoV-2, the virus that causes COVID-19,

Multi-year deal will enhance lab services for patients and providers throughout eastern Gulf Coast region BURLINGTON, N.C. --(BUSINESS WIRE)--Sep. 29, 2020-- LabCorp (NYSE: LH), a leading global life sciences company that is focused on advancing health and guiding patient care decisions, and

  BURLINGTON, N.C. --(BUSINESS WIRE)--Sep. 28, 2020-- LabCorp (NYSE: LH) will release its third quarter of 2020 financial results before the market opens on Tuesday, Oct. 27, 2020 , and then will host a conference call and webcast beginning at 9:00 a.m. EDT to discuss the results.

LabCorp Contacts: Media: Donald Von Hagen — 336-436-8263 Media@LabCorp.com Investors: Clarissa Willett — 336-436-5076 Investor@LabCorp.com GENFIT Contacts: Media: Hélène Lavin — +3 33 2016 4000 Helene.Lavin@genfit.com Investors: Naomi Eichenbaum — 617-714-5252 Investors@genfit.com LabCorp and

Blood-based test guides treatment decisions for patients with non-small cell lung cancer BURLINGTON, N.C. --(BUSINESS WIRE)--Sep. 23, 2020-- LabCorp (NYSE:LH), a leading global life sciences company that is focused on advancing health and guiding patient care decisions, has launched a new,

CHICAGO & BURLINGTON, N.C. --(BUSINESS WIRE)--Sep. 16, 2020-- Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare, and LabCorp (NYSE: LH), a leading global life sciences company, today announced a collaboration with

  LabCorp Expands Services in Louisiana and Mississippi Through Acquisition and Creation of a Comprehensive Clinical Laboratory Relationship   BURLINGTON, N.C., Sept. 10, 2020 — LabCorp (NYSE: LH), a leading global life sciences company that is focused on advancing health and guiding patient care

Single Test Detects Multiple Respiratory Infections Including COVID-19 and Flu to Inform Treatment Options At-Home Use Through Pixel by LabCorp™   Pending FDA Authorization BURLINGTON, N.C. --(BUSINESS WIRE)--Sep. 8, 2020-- LabCorp (NYSE: LH), a leading global life sciences company that is deeply

BURLINGTON, N.C. --(BUSINESS WIRE)--Sep. 1, 2020-- LabCorp (NYSE: LH) today announced that members of the executive management team will participate in a virtual fireside chat at the Baird’s 2020 Global Healthcare Conference on Wednesday, Sept. 9 at 11:25 a.m. ET .

No Charge Program Uses High-Affinity Test to Detect SARS-CoV-2 Antibodies BURLINGTON, N.C. --(BUSINESS WIRE)--Aug. 11, 2020-- LabCorp (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, today announced details of a no charge antibody testing program

More details of the three-month program will be provided in the near future. BURLINGTON, N.C. --(BUSINESS WIRE)--Jul. 30, 2020-- LabCorp (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, today announced plans to create a program to offer total

Q2 revenue of $2.8 billion , down (4%) from $2.9 billion last year Q2 diluted EPS of $2.37 , up 23% from $1.93 last year; Q2 adjusted EPS of $2.57 , down (12%) from $2.93 last year Q2 free cash flow of $272 million , up from $168 million last year Processed more than 8.5 million molecular COVID-19

New Method Aims to Improve Efficiency of COVID-19 Testing, Optimize Testing Supplies and Increase Overall Capacity BURLINGTON, N.C. --(BUSINESS WIRE)--Jul. 25, 2020-- LabCorp (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, today announced it

LabCorp’s Employer Services wellness screenings support effective workplace re-entry and management CHICAGO, July 22, 2020 – Health, safety and wellness are top of mind for employers as they bring workers back to the office while navigating dynamic local conditions.

Reports utilize LabCorp testing data related to conditions that have co-morbidities with other serious diseases, including increased COVID-19 risk BURLINGTON, N.C. --(BUSINESS WIRE)--Jul. 9, 2020-- LabCorp (NYSE: LH), a leading global life sciences company deeply integrated in guiding patient care,

Convenient LabCorp At Home Service Aims to Help Patients Resume Health Care, Treatments, and Surgeries BURLINGTON, N.C. --(BUSINESS WIRE)--Jul. 7, 2020-- LabCorp (NYSE: LH) today launched the LabCorp At Home COVID-19 Test Collection Service, the first seamless digital service aimed at helping

BURLINGTON, N.C. --(BUSINESS WIRE)--Jul. 6, 2020-- LabCorp (NYSE: LH) will release its second quarter of 2020 financial results before the market opens on Tuesday, July 28, 2020 , and then will host a conference call and webcast beginning at 9:00 a.m. EDT to discuss the results.

Advanced Analytics and Visualizations Empower Study Teams to Respond to Dynamic Environment, Manage Risk, Resume Studies and Safeguard Patients BURLINGTON, N.C. --(BUSINESS WIRE)--Jun. 29, 2020-- LabCorp (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient